{
  "@context": "aku-v2",
  "@type": "definition",
  "@id": "vascular:rare-syndromes:proteus:definition",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-05T17:22:00.000Z",
    "contributors": [
      "copilot"
    ],
    "status": "enhanced",
    "confidence": 0.91,
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/rare-syndromes",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "specialized",
    "board_yield": "LOW"
  },
  "content": {
    "term": "Proteus Syndrome",
    "synonyms": [
      "Wiedemann Syndrome"
    ],
    "definition": "An extremely rare mosaic overgrowth disorder caused by somatic activating mutations in AKT1, characterized by progressive, asymmetric, and disproportionate overgrowth of multiple tissues including bone, skin, connective tissue, and vascular structures. Named after the Greek god Proteus who could change shape.",
    "clinical_features": {
      "overgrowth": [
        "Progressive asymmetric overgrowth (hallmark)",
        "Cerebriform connective tissue nevi (pathognomonic)",
        "Hemihypertrophy",
        "Macrodactyly",
        "Bony overgrowth with distortion"
      ],
      "cutaneous": [
        "Cerebriform connective tissue nevi (soles of feet)",
        "Linear epidermal nevi",
        "Lipomas and lipomatosis",
        "Vascular malformations (capillary, venous, lymphatic)"
      ],
      "vascular": [
        "Complex vascular malformations",
        "Deep venous thrombosis (increased risk)",
        "Pulmonary embolism (major cause of mortality)",
        "Capillary malformations"
      ],
      "skeletal": [
        "Asymmetric limb overgrowth",
        "Scoliosis",
        "Skull hyperostosis",
        "Spinal abnormalities"
      ]
    },
    "pathophysiology": {
      "etiology": "Somatic activating mutation in AKT1 (c.49G>A, p.Glu17Lys)",
      "mechanism": "Hyperactivation of AKT-mTOR signaling pathway",
      "inheritance": "Sporadic (somatic mosaicism - constitutional mutation would be lethal)",
      "timing": "Overgrowth is minimal at birth, becomes progressive"
    },
    "diagnosis": {
      "criteria": "Established diagnostic criteria require specific combinations of features",
      "pathognomonic": "Cerebriform connective tissue nevus",
      "genetic": "Detection of AKT1 mutation in affected tissue",
      "imaging": "MRI/CT for extent of overgrowth",
      "differential": "Distinguish from CLOVES, Klippel-Trenaunay, hemihyperplasia"
    },
    "management": {
      "surveillance": [
        "DVT/PE prevention and monitoring (major mortality cause)",
        "Regular orthopedic evaluation",
        "Tumor surveillance (increased risk)"
      ],
      "thromboprophylaxis": [
        "Anticoagulation consideration",
        "Compression stockings",
        "Early mobilization"
      ],
      "surgical": [
        "Debulking procedures for functional impairment",
        "Orthopedic procedures for skeletal deformity",
        "Amputation rarely needed for severe overgrowth"
      ],
      "pharmacologic": [
        "AKT inhibitors (miransertib) - investigational",
        "Sirolimus - off-label, limited evidence"
      ]
    },
    "prognosis": {
      "life_threatening": "DVT/PE is major cause of premature mortality",
      "progressive": "Overgrowth continues through childhood, may stabilize",
      "functional": "Significant disability from progressive overgrowth"
    },
    "statement": "vascular:rare-syndromes:proteus:definition is a fundamental concept in Health-Sciences Medicine Surgery Vascular Rare-Syndromes that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding vascular:rare-syndromes:proteus:definition helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of vascular:rare-syndromes:proteus:definition include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of vascular:rare-syndromes:proteus:definition."
    }
  },
  "codes": {
    "snomed_ct": "30667009",
    "icd_10": "Q87.3",
    "orphanet": "744"
  },
  "relationships": {
    "broader": [
      "vascular:malformations:combined-syndromes",
      "genetics:akt-pathway"
    ],
    "related": [
      "vascular:rare-syndromes:cloves",
      "vascular:dvt:hypercoagulable"
    ],
    "narrower": []
  },
  "pedagogical": {
    "learning_objectives": [
      "Recognize pathognomonic cerebriform connective tissue nevus",
      "Understand AKT1 mutation and its effects",
      "Know DVT/PE is major mortality cause"
    ],
    "clinical_pearls": [
      "Cerebriform connective tissue nevus (soles) is PATHOGNOMONIC",
      "Overgrowth is minimal at birth - becomes progressive",
      "DVT/PE is leading cause of death - thromboprophylaxis essential",
      "Joseph Merrick ('Elephant Man') likely had Proteus syndrome, not neurofibromatosis"
    ]
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). vascular:rare-syndromes:proteus:definition. Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  }
}